Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New oral anticoagulants in patients with atrial fibrillation.
Opstelten W, van den Donk M, Kuijpers T, Burgers JS. Opstelten W, et al. Among authors: van den donk m. Lancet. 2014 Jul 5;384(9937):24. doi: 10.1016/S0140-6736(14)61104-1. Lancet. 2014. PMID: 24998808 No abstract available.
Towards a more efficient diabetes control in primary care: six-monthly monitoring compared with three-monthly monitoring in type 2 diabetes - The EFFIMODI trial. Design of a randomised controlled patient-preference equivalence trial in primary care.
Wermeling PR, van den Donk M, Gorter KJ, Ardine de Wit G, van der Graaf Y, Rutten GE. Wermeling PR, et al. Among authors: van der graaf y, van den donk m. BMC Fam Pract. 2010 May 11;11:35. doi: 10.1186/1471-2296-11-35. BMC Fam Pract. 2010. PMID: 20459820 Free PMC article. Clinical Trial.
Computerized decision support systems in primary care for type 2 diabetes patients only improve patients' outcomes when combined with feedback on performance and case management: a systematic review.
Cleveringa FG, Gorter KJ, van den Donk M, van Gijsel J, Rutten GE. Cleveringa FG, et al. Among authors: van gijsel j, van den donk m. Diabetes Technol Ther. 2013 Feb;15(2):180-92. doi: 10.1089/dia.2012.0201. Diabetes Technol Ther. 2013. PMID: 23360424 Review.
Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study.
Sandbæk A, Griffin SJ, Sharp SJ, Simmons RK, Borch-Johnsen K, Rutten GE, van den Donk M, Wareham NJ, Lauritzen T, Davies MJ, Khunti K. Sandbæk A, et al. Among authors: van den donk m. Diabetes Care. 2014 Jul;37(7):2015-23. doi: 10.2337/dc13-1544. Epub 2014 May 1. Diabetes Care. 2014. PMID: 24784827 Clinical Trial.
A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.
Simmons RK, Borch-Johnsen K, Lauritzen T, Rutten GE, Sandbæk A, van den Donk M, Black JA, Tao L, Wilson EC, Davies MJ, Khunti K, Sharp SJ, Wareham NJ, Griffin SJ. Simmons RK, et al. Among authors: van den donk m. Health Technol Assess. 2016 Aug;20(64):1-86. doi: 10.3310/hta20640. Health Technol Assess. 2016. PMID: 27583404 Free PMC article. Clinical Trial.
38 results